Neoleukin: Seattle-based Neoleukin folded into New York biotech after merger
The combined company is adopting the name of the New York City-based biotech, whose pre-merger shareholders now own most of the company.
Read full article »
Neoleukin is a Washington-based biotechnology company that researches and develops novel therapeutics for the treatment of cancer and autoimmune diseases.
Read more